The FORTA (Fit fOR The Aged)-EPI (Epidemiological) Algorithm: Application of an Information Technology Tool for the Epidemiological Assessment of Drug Treatment in Older People

[1]  C. Weiss,et al.  The FORTA (Fit fOR The Aged) List 2018: Third Version of a Validated Clinical Tool for Improved Drug Treatment in Older People , 2019, Drugs & Aging.

[2]  Thomas Kahan,et al.  [2018 ESC/ESH Guidelines for the management of arterial hypertension]. , 2019, Kardiologia polska.

[3]  M. Wehling,et al.  A systematic review and novel classification of listing tools to improve medication in older people , 2019, European Journal of Clinical Pharmacology.

[4]  I. Kunnamo,et al.  Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy , 2018, BMC Family Practice.

[5]  D. O’Mahony,et al.  Computerised interventions designed to reduce potentially inappropriate prescribing in hospitalised older adults: a systematic review and meta-analysis , 2018, Age and ageing.

[6]  M. Illario,et al.  A case study of polypharmacy management in nine European countries: Implications for change management and implementation , 2018, PloS one.

[7]  M. Wensing,et al.  Impact of a tailored program on the implementation of evidence-based recommendations for multimorbid patients with polypharmacy in primary care practices—results of a cluster-randomized controlled trial , 2017, Implementation Science.

[8]  L. Jacob,et al.  Impact of Disease Management Programs on HbA1c Values in Type 2 Diabetes Patients in Germany , 2017, Journal of diabetes science and technology.

[9]  C. Walker,et al.  Health professional perspectives on the management of multimorbidity and polypharmacy for older patients in Australia , 2016, Age and ageing.

[10]  B. Vaes,et al.  Too many, too few, or too unsafe? Impact of inappropriate prescribing on mortality, and hospitalization in a cohort of community-dwelling oldest old. , 2016, British journal of clinical pharmacology.

[11]  P. Gallagher,et al.  Prevention of Hospital‐Acquired Adverse Drug Reactions in Older People Using Screening Tool of Older Persons' Prescriptions and Screening Tool to Alert to Right Treatment Criteria: A Cluster Randomized Controlled Trial , 2016, Journal of the American Geriatrics Society.

[12]  C. Weiss,et al.  The FORTA (Fit fOR The Aged) List 2015: Update of a Validated Clinical Tool for Improved Pharmacotherapy in the Elderly , 2016, Drugs & Aging.

[13]  C. Weiss,et al.  VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification. , 2016, Age and ageing.

[14]  Ngaire Kerse,et al.  Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review , 2015, BMJ Open.

[15]  Mary Jordan Samuel.  American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults , 2015, Journal of the American Geriatrics Society.

[16]  A. Harugeri,et al.  Elderly patients’ participation in clinical trials , 2015, Perspectives in clinical research.

[17]  John B. Young,et al.  Improving recruitment of older people to clinical trials: use of the cohort multiple randomised controlled trial design. , 2015, Age and ageing.

[18]  D. Grandt,et al.  Influence of hospitalization on prescribing safety across the continuum of care: an exploratory study , 2015, BMC Health Services Research.

[19]  Nicole Brandt,et al.  Prevalence of Potentially Inappropriate Medication Use in Older Adults Using the 2012 Beers Criteria , 2015, Journal of the American Geriatrics Society.

[20]  Thomas Bürkle,et al.  Adverse drug events in patients admitted to an emergency department: an analysis of direct costs , 2015, Pharmacoepidemiology and drug safety.

[21]  Paul Gallagher,et al.  STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 , 2014, Age and ageing.

[22]  C. Vu,et al.  Inappropriate use of proton pump inhibitors in a local setting. , 2014, Singapore medical journal.

[23]  Joseph Hanlon,et al.  Clinical consequences of polypharmacy in elderly , 2014, Expert opinion on drug safety.

[24]  C. Weiss,et al.  Consensus Validation of the FORTA (Fit fOR The Aged) List: A Clinical Tool for Increasing the Appropriateness of Pharmacotherapy in the Elderly , 2013, Drugs & Aging.

[25]  S. Wyke,et al.  Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study , 2012, The Lancet.

[26]  G. Watts.  Why the exclusion of older people from clinical research must stop , 2012, BMJ : British Medical Journal.

[27]  Martin Wehling,et al.  GUIDELINE‐DRIVEN POLYPHARMACY IN ELDERLY, MULTIMORBID PATIENTS IS BASICALLY FLAWED: THERE ARE ALMOST NO GUIDELINES FOR THESE PATIENTS , 2011, Journal of the American Geriatrics Society.

[28]  M. Egger,et al.  Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis , 2011, BMJ : British Medical Journal.

[29]  M. Wehling,et al.  [Drug therapy in the elderly: too much or too little, what to do? A new assessment system: fit for the aged (FORTA]. , 2008, Deutsche medizinische Wochenschrift.

[30]  R. Page,et al.  The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. , 2006, The American journal of geriatric pharmacotherapy.

[31]  H. Quan,et al.  New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. , 2004, Journal of clinical epidemiology.

[32]  M. Beers,et al.  Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. , 1997, Archives of internal medicine.

[33]  C. Weiss,et al.  The EURO-FORTA (Fit fOR The Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People , 2018, Drugs & Aging.

[34]  M. Wehling.  Drug Therapy for the Elderly , 2013 .

[35]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[36]  D. Rolfson,et al.  Clinical Interventions in Aging Dovepress Physicians' Use of Computerized Clinical Decision Supports to Improve Medication Management in the Elderly – the Seniors Medication Alert and Review Technology Intervention , 2022 .